DocGo Q2 2026 earnings show a 9% revenue decline to $73.4M, impacted by migrant service winds down, despite strong growth in core segments.
DocGo Inc. reported Q2 2026 revenue of $73.4 million, down 9% year-over-year and below the $80.4 million consensus estimate. The decline was attributed to the wind down of migrant-related projects, although the company highlighted strong growth in its non-migrant business segments.
Key Takeaways
- Net revenue fell to $73.4 million from $80.4 million in Q2 2025, driven primarily by the reduction of migrant-related services.
- Medical Transportation Services revenue increased 5% year-over-year to $52 million, marking a record quarterly performance, despite rising fuel costs.
- Adjusted EBITDA loss narrowed to $6.3 million, a nearly 40% improvement from the prior quarter's loss of $10.3 million.
- Acquisition of hi Acuity Health will enhance DocGo's virtual care capabilities, with expectations of significant operational synergies.
- Guidance updated for full-year 2026 revenue to $305-$310 million, while adjusted EBITDA loss is expected to widen to $17-$22 million, reflecting longer-than-anticipated cost reductions.
Revenue Decline Driven by Migrant Services
Total revenue declined by 9% year-over-year to $73.4 million, down from $80.4 million in Q2 2025. Excluding the impact of migrant-related revenues, the company reported a 19% increase in core revenues, reflecting organic growth across its healthcare services.
| Metric | Q2 2026 | YoY | QoQ |
|---|---|---|---|
| Total Revenue | $73.4M | -9% | - |
| Medical Transportation Revenue | $52M | +5% | - |
| Adjusted EBITDA Loss | $6.3M | - | -40% |
The company’s Medical Transportation Services segment saw revenue rise 5% year-over-year, fueled by increased demand across key markets like New York and Texas. However, the segment's gross margin was constrained by escalating fuel costs, which rose from $3.16 per gallon a year ago to $4.27 in Q2 2026, impacting overall profitability.
Strategic Acquisition Enhances Growth Prospects
A key highlight of the quarter was the announcement of the acquisition of hi Acuity Health, a provider of telemedicine services, for an estimated $65 million in revenue. This acquisition aligns with DocGo's strategy to integrate technology into its care delivery model, enhancing its ability to offer comprehensive services from hospital to home.
Lee Beanstalk, CEO, emphasized that combining hi Acuity’s technology with DocGo’s existing platform will enable the company to provide a unified care model that addresses patient needs across various settings. The acquisition is expected to facilitate cross-selling opportunities and leverage existing relationships with health systems.
Efficiency Improvements and Cost Reduction Initiatives
DocGo has made significant strides in improving operational efficiency, resulting in a 40% reduction in adjusted EBITDA loss from the prior quarter. Management indicated that workforce reductions and AI-driven efficiency initiatives contributed to this improvement. The company has seen a reduction in its annual selling, general, and administrative (SGA) costs by approximately $4.5 million due to a corporate reduction in force.
Additionally, AI tools now handle 60% of patient communications, further driving down operational costs. The expectation is that these efficiency measures will yield approximately $6 million in annual savings once fully implemented.
Updated Guidance Reflects Challenges Ahead
As part of its quarterly update, DocGo revised its revenue guidance for the full year to $305-$310 million, which is an increase from previous guidance of $290-$300 million. However, the adjusted EBITDA loss is now projected to be wider than previously anticipated, with expectations of a loss between $17 million and $22 million compared to earlier estimates of $5 million to $10 million. The adjustment reflects slower-than-expected cost reductions and ongoing margin pressures as the company integrates its new acquisition.
Frequently Asked Questions
Did DocGo Inc. Common Stock beat earnings estimates in Q2 2026?
No, DocGo reported Q2 2026 revenue of $73.4 million, which was below the consensus estimate of $80.4 million.
What is the adjusted EBITDA loss for DocGo in Q2 2026?
The adjusted EBITDA loss for Q2 2026 was $6.3 million, an improvement of nearly 40% from the prior quarter's loss of $10.3 million.
What is the status of the hi Acuity Health acquisition?
DocGo has signed a definitive agreement to acquire hi Acuity Health, which generated approximately $65 million in revenue over the last twelve months.
How has fuel cost impacted DocGo’s financials?
Rising fuel costs have negatively impacted DocGo's gross margins, with fuel prices increasing from $3.16 per gallon in Q2 2025 to $4.27 in Q2 2026, restraining transport margins.
What is the expected revenue growth rate post-acquisition of hi Acuity Health?
hi Acuity Health is anticipated to grow at a low double-digit rate of about 10-12% annually, contributing to DocGo’s overall revenue growth strategy.
Looking ahead, the integration of hi Acuity Health and the execution of cost-saving measures will be critical for DocGo's performance in the coming quarters, particularly as the company aims to achieve a positive adjusted EBITDA run rate by year-end.
This analysis is based on public earnings call materials and is not investment advice.
